Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|November 22, 2011
A pilot study of the novel offset-tip papillotome for selective biliary cannulation in ERCPHiroo Imazu, Keiichi Ikeda, Hiroshi Kakutani, et al.
Scandinavian Journal of Gastroenterology|April 18, 2012
Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinomaHiroo Imazu, Keisuke Kanazawa, Naoki Mori, et al.
Digestive Diseases and Sciences|March 26, 2014
Contrast-enhanced harmonic endoscopic ultrasonography in the differential diagnosis of gallbladder wall thickeningHiroo Imazu, Naoki Mori, Keisuke Kanazawa, et al.
Scandinavian Journal of Gastroenterology|September 5, 2012
A comparison of electronic radial and curvilinear endoscopic ultrasonography in the detection of pancreatic malignant tumorKeisuke Kanazawa, Hiroo Imazu, Naoki Mori, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouseHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Oncology Reports|June 7, 2003
Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma developmentHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Oncology Reports|July 29, 2003
The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppressionHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 6, 2003
Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis developmentHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Pageof 7